Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  palonosetron hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-17 of 17 for your search:
Start Over
AMENO-2: Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors
Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-00055-18, NCT00415103
Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: P04594, NCT00687011
Efficacy and Safety of Palonosetron Hydrochloride in the Prevention of Nausea and Vomiting
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: zhiruo, NCT01481831
Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000544841, U10CA037420, URCC-U1105, URCC-04-02, U1105, NCT00475085
Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2006-0841, MDA-2006-0841, CDR0000573510, NCI-2009-00637, NCT00553059
Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: GAND-emesis, 2009-014691-21, NCT01074697
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: NETU-08-18, NCT01339260
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PALO-10-01, NCT01363479
Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: 2005-0506, NCT00412425
Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Palonosetron in Cancer Treated With Chemotherapy
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: PAL/SC-IV-2008, 2008-002853-19, NCT01046240
Multi-day Doses in Prevention of Nausea and Emesis
Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: 10862, KUMC-10862, MGI-KUMC-10862, NCT00631930, NCT00600353
Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer
Phase: Phase II
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000642449, NCCTG-N08C2, N08C2, NCT00903396
Intravenous Palonosetron With Radiotherapy and Concomitant Temozolomide
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 to 90
Sponsor: Other
Protocol IDs: Pro00015573, P50NS020023, NCT00900757
Phase II Trial Evaluating the Efficacy and Tolerability of Aprepitant & Palonosetron for Prevention of Chemotherapy-Induced Nausea and Vomiting
Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000503649, OHSU-SOL-06006-LM, OHSU-IRB-2302, 2302, NCT00381862
Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer
Phase: No phase specified
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 6140, NCI-2010-00801, UWCC-6140, UWCC-UW-6140, UWCC-05-9579-H/D, FHCRC-6140, MGI-FHCRC-6140, NCT00343863
Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)
Phase: No phase specified
Type: Supportive care, Treatment
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: 2005-0664, NCT00410488
Start Over